This study was to investigate the quinolones resistance to gram-positive cocci isolated in the First Bethune Hospital during the past 8 years. Disk diffusion test was used to study the antimicrobial resistance. The data were analyzed by WHONET 5 software according to Clinical and Laboratory Standards Institute (CLSI). The rates of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococci (MRCNS) were 50.8~83.3 and 79.4~81.5 during the past 8 years, respectively. In recent 8 years, the quinolones resistance to gram-positive cocci had increased. Monitoring of the quinolones resistance to gram-positive cocci should be strengthened. The change of the antimicrobial resistance should be investigated in order to guide rational drug usage in the clinic and prevent bacterial strain of drug resistance from being transmitted.
1.Introduction
High prevalences of quinolones resistance in gram-positive cocci have been described in America and Asia [1] [2] [3] . In Staphylococcus aureus and coagulase-negative Staphylococci, quinolones resistance has been more frequently found among methicillin-resistant Staphylococci spp strains than among methicillin-sensitive Staphylococci spp strains, which may be related to the mecA-mediated resistance. The objectives of this study were to investigate the quinolones resistance to gram-positive cocci in 8 consecutive years in the First Bethune Hospital.
2.Materials and methods

2.1.Bacterial isolates
Consecutive nonduplicate nosocomial isolates of gram-positive cocci were collected during the period from 2003 to 2010 in the First Bethune Hospital. Isolates were identified at the species level using standard biochemical tests and microbiological methods.
2.2.Antimicrobial susceptibility testing
Antimicrobial susceptibility testing. The susceptibilities of gram-positive cocci to 3 quinolones agents were determined by the disk diffusion method in accordance with CLSI guidelines.
2.3.Detection of MRSA and MRCNS production
Detection of MRSA and MRCNS production was according to CLSI. Staphylococcus aureus ATCC 25923 and Staphylococcus aureus ATCC 43300 strains served as quality controls.
3.Results
The rates of MRSA were 50.8% (31/61), 58. The resistance of MRSA, MRSCN, Enterococcus faecalis, Enterococcus faecium to ciprofloxacin was more than 50%, however, the resistance of MSSA and MSCNS to ciprofloxacin was no more than 30% during the past 8 years. Overall, the resistance of MRSA, MRSCN, Enterococcus faecalis, Enterococcus faecium to levofloxacin and gatifloxacin was more than 40%, however, the resistance of MSSA and MSCNS to levofloxacin and gatifloxacin was no more than 25% during the past 8 years. In recent 8 years, the quinolones resistance to gram-positive cocci had increased.
The resistance of gram-positive cocci to quinolones is shown in table 1
4.Discussion
The current study showed prevalence of MRSA and MRCNS range from 50.8~83.3 to 79.4%~81.5% in Staphylococcus aureus and coagulase-negative Staphylococci in the First Bethune Hospital, respectively. The resistance rates of methicillin-resistant Staphylococci spp to quinolones were much higher than those of methicillin-sensitive Staphylococci spp in 8 consecutive years in the First Bethune Hospital. Our study showed the resistance rates of Enterococcus faecalis and Enterococcus faecium to quinolones were also very high.
Three mechanisms of resistance to quinolones are currently recognized: mutations that alter the drug targets, mutations that reduce drug accumulation, and plasmids that protect cells from the lethal effects of quinolones. Broad use of quinolones has been followed by emergence of resistance, which has been due mainly to chromosomal mutations in genes encoding the subunits of the drug target enzymes, DNA gyrase and topoisomerase IV, and in genes that affect the expression of diffusion channels in the outer membrane and multidrug-resistance efflux systems. Recently, qnr genes, aac(6 )-Ib-cr gene, quinolones efflux pump protein QepA have involved. In Staphylococcus aureus, resistance to quinolones is associated with increased expression of norA, a gene that encodes a broad-spectrum transporter for quinolones and other agents. It is alerted that too much quinolone have been used in China.
Monitoring antibiotic use with microbiology laboratory support can promote rational drug utilization, cut costs and delay the emergence of resistant organisms.
